313 related articles for article (PubMed ID: 27007153)
21. Prognostic significance of Beclin-1 expression in laryngeal squamous cell carcinoma.
Huang L; Wang S; Li SS; Yang XM
Pathol Oncol Res; 2013 Oct; 19(4):771-7. PubMed ID: 23686476
[TBL] [Abstract][Full Text] [Related]
22. p63 and Ki-67 immunostainings in laryngeal squamous cell carcinoma are related to survival.
Re M; Zizzi A; Ferrante L; Stramazzotti D; Goteri G; Gioacchini FM; Olivieri F; Magliulo G; Rubini C
Eur Arch Otorhinolaryngol; 2014 Jun; 271(6):1641-51. PubMed ID: 24402377
[TBL] [Abstract][Full Text] [Related]
23. CISD2 associated with proliferation indicates negative prognosis in patients with hepatocellular carcinoma.
Chen B; Shen S; Wu J; Hua Y; Kuang M; Li S; Peng B
Int J Clin Exp Pathol; 2015; 8(10):13725-38. PubMed ID: 26722601
[TBL] [Abstract][Full Text] [Related]
24. Clinical value of serum HMGB1 in diagnosis and prognosis of laryngeal squamous cell carcinoma.
Qiu G; Li Y; Liu Z; Wang M; Ge J; Bai X
Med Oncol; 2014 Dec; 31(12):316. PubMed ID: 25373322
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of ROCK1 and ROCK2 inhibits human laryngeal squamous cell carcinoma.
Zhang J; He X; Ma Y; Liu Y; Shi H; Guo W; Liu L
Int J Clin Exp Pathol; 2015; 8(1):244-51. PubMed ID: 25755711
[TBL] [Abstract][Full Text] [Related]
26. Expression and prognostic value of MAGE-A9 in laryngeal squamous cell carcinoma.
Han L; Jiang B; Wu H; Zhang S; Lu X
Int J Clin Exp Pathol; 2014; 7(10):6734-42. PubMed ID: 25400753
[TBL] [Abstract][Full Text] [Related]
27. Nuclear survivin expression correlates with endoglin-assessed microvascularisation in laryngeal carcinoma.
Marioni G; Ottaviano G; Marchese-Ragona R; Fasanaro E; Tealdo G; Zanotti C; Randon B; Giacomelli L; Stellini E; Blandamura S
J Clin Pathol; 2017 Dec; 70(12):1033-1037. PubMed ID: 28446541
[TBL] [Abstract][Full Text] [Related]
28. Expression of ABC transporters is an unfavorable prognostic factor in laryngeal squamous cell carcinoma.
Shen B; Li D; Dong P; Gao S
Ann Otol Rhinol Laryngol; 2011 Dec; 120(12):820-7. PubMed ID: 22279954
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of integrin-linked kinase in laryngeal squamous cell carcinoma.
Wu PA; Li SS; Tang QL; Liu BB; Yang XM
Auris Nasus Larynx; 2017 Aug; 44(4):458-463. PubMed ID: 28188026
[TBL] [Abstract][Full Text] [Related]
30. Upregulated TIMP-1 correlates with poor prognosis of laryngeal squamous cell carcinoma.
Ma J; Wang J; Fan W; Pu X; Zhang D; Fan C; Xiong L; Zhu H; Xu N; Chen R; Liu S
Int J Clin Exp Pathol; 2014; 7(1):246-54. PubMed ID: 24427345
[TBL] [Abstract][Full Text] [Related]
31. HPV Infection and Anemia Status Stratify the Survival of Early T2 Laryngeal Squamous Cell Carcinoma.
Wang H; Zhang Z; Sun R; Lin H; Gong L; Fang M; Hu WH
J Voice; 2015 May; 29(3):356-62. PubMed ID: 25484261
[TBL] [Abstract][Full Text] [Related]
32. Spondin-2 is a novel diagnostic biomarker for laryngeal squamous cell carcinoma.
Ni H; Ni T; Feng J; Bian T; Liu Y; Zhang J
Pathol Res Pract; 2019 Feb; 215(2):286-291. PubMed ID: 30527359
[TBL] [Abstract][Full Text] [Related]
33. High microRNA-23a expression in laryngeal squamous cell carcinoma is associated with poor patient prognosis.
Zhang XW; Liu N; Chen S; Wang Y; Zhang ZX; Sun YY; Qiu GB; Fu WN
Diagn Pathol; 2015 Apr; 10():22. PubMed ID: 25879432
[TBL] [Abstract][Full Text] [Related]
34. [Correlation of EphA2 protein expression with clinicopathological characteristics and prognosis in laryngeal squamous cell carcinoma].
Liu Y; Zhang X; Qiu YZ; Huang DH; Zhou XJ; Tan PQ; Cai GM; Dai YZ; Yu CY; Xiao JY; Tian YQ
Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):197-201. PubMed ID: 21575519
[TBL] [Abstract][Full Text] [Related]
35. Increased expression of metadherin protein predicts worse disease-free and overall survival in laryngeal squamous cell carcinoma.
Liu Y; Su Z; Li G; Yu C; Ren S; Huang D; Fan S; Tian Y; Zhang X; Qiu Y
Int J Cancer; 2013 Aug; 133(3):671-9. PubMed ID: 23364922
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of HAX-1 expression in laryngeal carcinoma.
You Y; Yao H; You B; Li X; Ni H; Shi S; Shan Y; Cao X
Auris Nasus Larynx; 2015 Aug; 42(4):299-304. PubMed ID: 25554539
[TBL] [Abstract][Full Text] [Related]
37. DIRC3 and near NABP1 genetic polymorphisms are associated laryngeal squamous cell carcinoma patient survival.
Shen Z; Ren W; Bai Y; Chen Z; Li J; Li B; Jin T; Cao P; Shao Y
Oncotarget; 2016 Nov; 7(48):79596-79604. PubMed ID: 27793000
[TBL] [Abstract][Full Text] [Related]
38. Aberrant Kif2a and Ki67 expression predicts poor survival in laryngeal squamous cell carcinoma.
Zhang Q; Zhang W; Zhang J; Xu H; You Y
Auris Nasus Larynx; 2016 Aug; 43(4):433-9. PubMed ID: 26602436
[TBL] [Abstract][Full Text] [Related]
39. Roles of KAI1 and nm23 in lymphangiogenesis and lymph metastasis of laryngeal squamous cell carcinoma.
Zheng Z; Tian R; Wang P
World J Surg Oncol; 2017 Nov; 15(1):211. PubMed ID: 29187211
[TBL] [Abstract][Full Text] [Related]
40. Phosphorylated FADD is not prognostic for local control in T1-T2 supraglottic laryngeal carcinoma treated with radiotherapy.
Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik M; Langendijk JA; de Bock GH; Roodenburg JL; van der Laan BFAM; van der Wal JE; Schuuring E
Laryngoscope; 2017 Sep; 127(9):E301-E307. PubMed ID: 28304089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
